Skip to main content

Want a detailed portfolio tracker?

Autolus Therapeutics (AUTL) P/E (2022 - 2026)

Autolus Therapeutics (AUTL) P/E from Sep 30, 2022 to Jul 21, 2026. The TTM Autolus Therapeutics (AUTL) P/E is -1.45. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Autolus Therapeutics (AUTL)

YearP/EChange
2026-1.45-23.50%
2025-1.90-17.03%
2024-2.29-56.55%
2023-5.26+30.07%
2022-4.04N/A

Comparison Autolus Therapeutics (AUTL) P/E with competitors

Autolus Therapeutics (AUTL) P/E is -1.45.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.30%
ENLVEnlivex Ltd0.07-105.16%
FGENFibroGen Inc0.24-116.55%
CHRSCoherus Biosciences Inc0.85-158.50%
FBIOFortress Biotech Inc0.95-165.43%
ORMPOramed Pharmaceuticals Inc1.50-203.62%
AGENAgenus Inc3.01-307.48%
INVAInnoviva Inc3.15-317.44%
VXRTVaxart Inc3.55-344.72%
CRMDCorMedix Inc3.63-350.14%
CVACCureVac N.V.4.45-406.48%
GLPGGalapagos NV4.86-434.97%
SRPTSarepta Therapeutics Inc4.88-436.57%
ABEOAbeona Therapeutics Inc5.39-471.41%
ABUSArbutus Biopharma Corp5.60-485.76%
ZVRAZevra Therapeutics Inc5.89-505.86%
SPROSpero Therapeutics Inc6.23-529.39%
CGENCompugen Ltd6.31-535.28%
RIGLRigel Pharmaceuticals6.87-573.76%
SLXNSilexion Therapeutics Corp7.30-602.99%
OMEROmeros Corporation9.26-738.29%
AUPHAurinia Pharmaceuticals Inc9.58-760.78%
PLXProtalix BioTherapeutics Inc10.89-850.82%
ACADAcadia Pharmaceuticals Inc11.73-908.56%
TBPHTheravance Biopharma Inc12.26-945.35%
ADMAAdma Biologics Inc12.42-956.10%
HRMYHarmony Biosciences Holdings Inc13.82-1052.76%
SABSSAB Biotherapeutics Inc14.14-1074.55%
NAGENiagen Bioscience Inc14.82-1121.56%
INCYIncyte Corp15.82-1190.80%
REGNRegeneron Pharmaceuticals Inc15.86-1193.15%
PBYIPuma Biotechnology Inc17.32-1293.74%
CPRXCatalyst Pharmaceuticals Inc17.44-1302.26%
EXELExelixis Inc17.54-1309.07%
TGTXTG Therapeutics Inc18.97-1407.51%
MDXGMimedx Group Inc20.55-1516.88%
XOMAXOMA Royalty Corp22.87-1677.02%
ARGXArgen X SE24.30-1775.14%
CTMXCytomX Therapeutics Inc24.82-1811.21%
XOMAOXOMA Royalty Corp25.34-1847.31%
HALOHalozyme Therapeutics Inc25.62-1866.54%
XOMAPXOMA Royalty Corp25.67-1869.74%
VRTXVertex Pharmaceuticals Inc27.99-2030.00%
RPRXRoyalty Pharma plc - Class A28.69-2077.76%
SLNOSoleno Therapeutics Inc29.02-2100.36%
ASNDAscendis Pharma A/S30.09-2174.14%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2713.71%
APLSApellis Pharmaceuticals Inc39.02-2790.18%
BMRNBiomarin Pharmaceutical Inc42.21-3010.15%
KRYSKrystal Biotech Inc45.34-3226.05%
ONCBeiGene Ltd69.54-4894.23%
PHARPharming Group N.V.75.03-5272.38%
TECHBio-Techne Corp101.96-7129.17%
VCELVericel Corp109.92-7678.15%
ALNYAlnylam Pharmaceuticals Inc117.96-8232.70%
GMABGenmab140.29-9771.87%
TLXTelix Pharmaceuticals Ltd162.15-11279.07%
CORTCorcept Therapeutics Inc212.86-14774.74%